Treatment with granulocyte colony-stimulating factor in patients with repetitive implantation failures and/or recurrent spontaneous abortions

Journal of Reproductive Immunology

Volumn 108, Issue , 2015, Pages 123-135

  Würfel, Wolfgang ^a  

^a KCM   (Germany)

Author keywords

Granulocyte colony stimulating factor (G CSF); Recurrent spontaneous abortion (RSA); Repetitive implantation failure (RIF)

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

EMBRYO DEVELOPMENT; ENDOMETRIUM; HUMAN; MELANOMA; NIDATION; NONHUMAN; OOCYTE MATURATION; PHYSIOLOGY; PREGNANCY DISORDER; PREGNANCY OUTCOME; PREGNANCY RATE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; RECURRENT ABORTION; REPRODUCTION; REVIEW; RISK ASSESSMENT; SPERMATOZOON MATURATION; SPONTANEOUS ABORTION; TISSUE DISTRIBUTION; TREATMENT INDICATION; ANIMAL; ANIMAL MODEL; CELL DIFFERENTIATION; FEMALE; IMMUNOLOGY; METABOLISM; OOCYTE; RECURRENT DISEASE; TRENDS;

ABORTION, SPONTANEOUS; ANIMALS; CELL DIFFERENTIATION; EMBRYO IMPLANTATION; ENDOMETRIUM; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; MODELS, ANIMAL; OOCYTES; RECURRENCE; REPRODUCTIVE MEDICINE;

EID: 84926256097     PISSN: 01650378     EISSN: 18727603     Source Type: Journal    
DOI: 10.1016/j.jri.2015.01.010     Document Type: Review

References (188)

1. Aapro M.S., Bohlius J., Cameron D.A., Dal Lago L., Donelly J.P., Kearney N., Lyman G.H., Pettengeil R., Tjan-Heijnen V.C., Walewski J., Weber D.C., Zielinski C. 2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumors. Eur. J. Cancer 2011, 47:8-32.
2. Abe T., Azuma H., Watanabe A., Shigekiyo T., Endou S., Pou R., Fukui P., Maeda K., Aono T., Matsumoto T. A patient with cyclic neutropenia complicated by severe neutropenia successfully delivered a healthy baby. Intern. Med. 2000, 39:663-666.
3. Adusumilli A., Kattepogu R.R., Krothapalli S.R. The clinical applications of hemopoietic growth factor - GCSF. Blood 2012, 1119:5063-5064.
4. Anderlini P., Chan F.A., Champlin R.E., Körbling M., Strom S.S. Long term follow-up of normal peripheral blood progenitor cell donors treated with filgrastim: no evidence of increased risk of leukemia development. Bone Marrow Transplant. 2002, 30:661-663.
5. Aoki Y., Sha S., Mukai H., Nishi Y. Selective stimulation of G-CSF gene expression in macrophages by a stimulatory monoclonal antibody as detected by a luciferase reporter gene assay. J. Leukoc. Biol. 2000, 68:757-764.
6. Avalos B., Lazaryan A., Copelan E. Can G-CSF cause leukemia in hematopoietic stem cell donors. Biol. Blood Marrow Transplant. 2011, 17:1739-1746.
7. Aviles A., Neri N. Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero. Clin. Lymphoma 2001, 2:173-177.
8. Bailie K.E., Irvine A.E., Bridges J.M., McClure B.G. Granulocyte and granulocyte-macrophage colony-stimulating factors in cord and maternal serum at delivery. Pediatr. Res. 1994, 35:164-168.
9. Bazan J. Structural design and molecular evolution of a cytokine receptor superfamily. Proc. Natl. Acad. Sci. U. S. A. 1990, 87:6934-6938.
10. Boggess K.A., Greig P.C., Murtha A.P., Jimmerson C.E., Herbert W.N. Maternal serum granulocyte-colony stimulating factor in preterm birth with subclinical chorioamnionitis. J. Reprod. Immunol. 1997, 33:45-52.
11. Boxer L.A., Boyard A.A., Marrero T.T., Alter B.P., Bonilla M.A., Link D., Newburger P.E., Rosenberg P.S., Shimamura A., Dale D.C. 1490 outcomes of pregnancies for women with severe chronic neutropenia with and without G-CSF treatment, Hematology. 52nd ASH Annual Meeting 2010, Abstract 4786.
12. Braunstein K.D. Untersuchungen zur Regulation von Interleukin-1β (IL-1β), granulocyte colony stimulating factor (G-CSF) und vascular endothelial growth factor (vegf) in humane endometrium 2007, (PhD thesis), Ludwig-Maximilians-Universität, Munich, Germany.
13. Burgess A., Metcalf D. Characterization of a serum factor stimulating the differentiation of myelomonocytic leukemia stem cells. Int. J. Cancer 1980, 26:247-254.
14. Bussolino F., Wang J.M., Defilippi P., Turrini F., Sanavio F., Edgeli C.S., Aglietta M., Arese P., Mantovani A. Granulocyte- and granulocyte-macrophage colony-stimulating factors induce human endothelial cells to migrate and proliferate. Nature 1989, 337:471-473.
15. Calder C., Hays S.R., Manes B., Lavin V.A., Ho R.H., Frangoul H. Successful bone marrow harvest during pregnancy. Bone Marrow Transplant. 2005, 35:631-632.
16. Calhoun D.A., Christensen R.D. A randomised pilot trial of administration of granulocyte colony-stimulating factor to women before preterm delivery. Am. J. Obstet. Gynecol. 1998, 179:766-771.
17. Calhoun D.A., Donnelly W.H., Du Y., Dame J.B., Li Y., Christensen R.D. Distribution of granulocyte colony-stimulation factor (G-CSF) and G-CSF-receptor mRNA and protein in the human fetus. Pediatr. Res. 1999, 46:333-338.
18. Calhoun D.A., Lunoe M., Du Y., Christensen R.D. Granulocyte colony-stimulating factor is present in human milk and its receptor is present in human fetal intestine. Pediatrics 2000, 105:e7.
19. Calhoun D.A., Chegini N., Pollioti B.M., Gersting J.A., Miller R.K., Christensen R.D. Granulocyte colony-stimulating factor in preterm and term pregnancy, parturition, and intra-amniotic infection. Obstet. Gynecol. 2001, 97:229-234.
20. Calhoun D.A., Gersting J.A., Lunoe M., Du Y., Christensen R.D. Transfer of recombinant human granulocyte colony stimulating factor (rhG-CSF) from the maternal to the fetal circulation is not dependent upon a functional G-CSF receptor. Placenta 2001, 22:609-612.
21. Cardonick E., Irfan F., Torres N. The use of Neupogen (filgrastim) or Neulasta (pegfilgrastim) during pregnancy when chemotherapy is indicated for maternal cancer treatment. J. Cancer Ther. 2012, 3:157-161.
22. Carter, D.L., 2009. Method for reducing the risk of spontaneous abortion in a human female subject. US Patent 8338373.
23. Carter, D.L., 2012. Compositions and methods for reducing the risk of preterm labour. US Patent 8481488.
24. Carter, D.L., 2013. Compositions and methods for the reducing the risk of preeclampsia. US Patent 8470775 B2.
25. Cavallaro A.M., Lilleby K., Majolino I., Appelbaum F.R., Rowley S.D., Bensinger W.I. Three to six year follow-up of normal donors who received recombinant human granulocyte colony-stimulating factor. Bone Marrow Transplant. 2000, 25:85-89.
26. Cavenagh J.D., Richardson D.S., Cahill M.R., Bernard T., Kelsey S.M., Newland A.C. Treatment of acute myeloid leukemia in pregnancy. Lancet 1995, 346:441-442.
27. Chakraborty A., Guha S. Granulocyte colony-stimulating factor/granulocyte colony-stimulating factor receptor biological axis promotes survival and growth of bladder cancer cells. Urology 2007, 69:1210-1215.
28. Cheknev S.B., Apresova M.A., Moryakowa N.A., Efremova I.E., Mezdrokhina A.S., Piskovskaya L.S., Babajanz A.A. Production of the growth factors GM-CSF, G-CSF, and VEGF by peripheral blood cells induced with metal complexes of human serum y-globulin formed with copper or zinc ions. Mediators Inflamm. 2014, ID 518265. 10.1155/2014/518265.
29. Claahsen H.L., Semmekrot B.A., van Dongen P.W.J., Mattijssen V. Successful fetal outcome after exposure to idarubicin and cytosine-arabinoide during the second trimester of pregnancy: a case report. Am. J. Perinatol. 1998, 15:295-297.
30. Cottle T.E., Fier C.J., Donadieu J., Kinsey S.E. Risk and benefit of treatment of severe chronic neutropenia with granulocyte colony-stimulating factor. Semin. Hematol. 2002, 39:134-140.
31. Crawford J., Caserta C., Rolla F., On behalf of the ESMO guidelines working group Hematopoietic growth factors: ESMO clinical practice guidelines for the applications. Ann. Oncol. 2010, 21(Suppl. 5):v248-v251.
32. Cuturi M.C., Anegón I., Sherman F., Loudon R., Clark S.C., Perussia B., Trinchieri G. Production of hematopoietic colony-stimulating factors by human natural killer cells. J. Med. Exp. 1989, 169:569-583.
33. Dale D.C., Cottle T.E., Fier C.J., Bolyard A.A., Bonilla M.A., Boxer L.A., Cham B., Freedman M.H., Kannourakis G., Kinsey S.E., Davis R., Scarlata D., Schwinzer B., Zeidler C., Welte K. Severe chronic neutropenia treatment and follow-up of patients in the Severe Chronic Neutropenia International Registry. Am. J. Hematol. 2003, 72:82-93.
34. Demetri G.D., Griffin J.D. Granulocyte colony-stimulating factor and its receptor. Blood 1991, 78:2791-2808.
35. Deutsche Krebsgesellschaft, Deutsche Gesellschaft für Gynäkologie und Geburtshilfe Interdisziplinäre S3-Leitlinie für Diagnostik, Therapie und Nachsorge des Mammakarzinoms 2012, AWMF Reg. No. 032-045OL.
36. Deutsche Krebsgesellschaft, Deutsche Krebshilfe S3-Leitlonie Diagnostik, Therapie und Nachsorge des Hodgkin-Lymphoms bei erwachsenen Patienten 2013, AWMF Reg. No. 018/029/OL.
37. Duan J.S. Production of granulocyte colony stimulating factor in decidual tissue and its significance in pregnancy. Osake City Med. J. 1990, 36:81-97.
38. Fahey J.V., Schaefer T.M., Channon J.Y., Wira C.R. Secretion of cytokines and chemokines by polarized human epithelial cells from the female reproductive tract. Hum. Reprod. 2005, 20:1439-1446.
39. Falandry C., Campone M., Cartron G., Guerrin D., Freyer G. Trends in G-CSF use in 990 patients after EORTC and ASCO guidelines. Eur. J. Cancer 2010, 46:2389-2398.
40. Falkenburg F. G-CSF: early benefits but late risks?. Blood 2001, 97:2194.
41. Fang H., Liu A., Sun J., Kitz A., Dirsch O., Dahmen U. Granulocyte colony stimulating factor induces lipopolysaccharide (LPS) sensitization via upregulation of LPS binding protein in rat. PLOS ONE 2013, 8:e56654.
42. Fibbe W.E., van Damme J., Billiau A., Duinkerken N., Lurvink E., Ralph P., Altrock B.W., Kaushansky K., Willemze R., Falkenburg F. Human fibroblasts produce granulocyte-CSF, macrophage-CSF, and granulocyte-macrophage-CSF following stimulation by Interleukin-1 and Poly(rI).Poly(rC). Blood 1988, 72:860-866.
43. Freedman M.H., Bonilla M.A., Fier C., Bolyard A.A., Scarlata D., Boxer L.A., Brown S., Cham B., Kannourakis G., Kinsay S.E., Mori P.G., Cottle T., Welte K., Dale D.C. Myelodysplasia syndrome and acute myeloid leukemia in patients with congenital neutropenia receiving G-CSF therapy. Blood 2000, 96:429-436.
44. Fujii R., Shibata T., Neyatani N., Waseda T., Makinoda S., Utsunomiya T. Granulocyte colony-stimulating factor (G-CSF) prevents luteinized unruptured follicle (LUF) caused by clomiphene treatment. Fertil. Steril. 2013, 100(Suppl. 1):258.
45. Franzke A., Piao W., Lauber J., Gatzlaff P., Könecke C., Hansen W., Schmitt-Thomsen A., Hertenstein B., Buer J., Ganser A. G-CSF as immune regulator in T cells expressing the G-CSF receptor: implications for transplantation and autoimmune diseases. Blood 2003, 102:702-739.
46. Frydman R., Osipova A., Piccinni M.P., Petitbarat M., Frydman N., Lédée N. The predictive role of granulocyte colony-stimulating factor and other cytokines in follicular fluid on the embryo implantation. Fertil. Steril. 2009, 92(Suppl. 1):249.
47. Fukunaga R., Seto Y., Mizushima S., Nagata S. Three different mRNAs encoding human granulocyte colony-stimulating factor receptor. Proc. Natl. Acad. Sci. U. S. A. 1990, 87:8702-8706.
48. Fujii R., Neyatani N., Waseda T., Oka Y., Takgi H., Tomizawa H., Sasagawa T., Makinoda S. The involvement of granulocyte colony-stimulating factor (G-CSF) in the release of a mature oocyte. Hum. Reprod. 2011, 26(Suppl. 1):310-311.
49. Gleicher N., Kim A., Michaeli T., Lee H.J., Shohat-Tal A., Lazzaroni E., Barad D.H. A pilot cohort study of granulocyte colony-stimulating factor in the treatment of unresponsive thin endometrium resistant to standard therapies. Hum. Reprod. 2013, 28:172-177.
50. Gnoth C. Results of G-CSF Application in RIF Patients 2014, (unpublished data).
51. Halter J., Kodera Y., Ipsizua A.U., Greinix H.T., Schmitz N., Favre G., Baldomero H., Niederwieser D., Apperley J.F., Gratwohl A. Severe events in donors after allogeneic hematopoietic stem cell donation. Haematologica 2009, 94:94-101.
52. Hepp P., Rack B., Schneider M., Rezai M., Tesch H., Beck T., Söling U., Lichtenegger W., Beckmann M.W., Janni W. Effects of G-CSF on circulating tumor cells (CTC) and CA27.29 in breast cancer patients. J. Clin. Oncol. 2009, 27:15S. (abstract 11027).
53. Herrler A., von Rango U., Beier H.M. Embryo-maternal signalling: how the embryo starts talking to its mother to accomplish implantation. Reprod. BioMed. Online 2003, 6:244-256.
54. Hiby S.E., Regan L., Lo W., Carrington M., Moffat A. Association of maternal killer-cell-immunoglobulin-like receptors and paternal HLA-C genotypes with recurrent miscarriage. Hum. Reprod. 2008, 23:972-976.
55. Hiby S.E., Apps R., Sharkey A.M., Farrell L.E., Gardner L., Mulder A., Claas F.H., Walker J.J., Redman C.W., Morgan L., Tower C., Regan L., Moore G.E., Carrington M., Moffat A. Maternal activating KIRs protect against human reproductive failure mediated by fetal HLA-C2. J. Clin. Invest. 2010, 120:4102-4110.
56. Hirsch B., Oseth L., Cain M., Trader E., Pulkrabek S., Lindgren B., Luo X., Clay M., Miller J., Confer D., Weisdorf D., McCullough J. Effects of granulocyte-colony stimulating factor on chromosome aneuploidy and replication asynchrony in healthy peripheral blood stem cell donors. Blood 2011, 118:2602-2608.
57. Hirv K., Würfel W. Profiling of receptors on natural killer cells - our results in infertility patients and first clinical applications. 8th Congress European Society of Reproductive Immunology 2010.
58. Hönig A., Engel J.B., Segerer S.E., Kranke P., Häusler S., Würfel W. Pregnancy triggered antiphospholipid syndrome in a patient with multiple late miscarriages. Hum. Reprod. 2010, 25:2753-2754.
59. Jenderek C., Hepp P., Rack B., Schindlbeck C., Thurner-Hermanns E., Schlag R., Hönig A:., Zoche H., Christl K., Oberlechner E., Beckmann M.W., Janni W., Friese K. Auswirkungen von G-CSF auf zirkulierende Tumorzellen (CTC) und CA27.29 bei Patientinnen mit Mammacarcinom. Geburtsh. Frauenheilk. 2009, 69:P135.
60. Jeong W., Kim J., Bazer F.W., Song G. Proliferation-stimulating effect of colony stimulating factor 2 on porcine trophectoderm cells is mediated by activation of phosphatidylinositol 3-kinase and extracellular signal-related kinase 1/2 mitogen-activated protein kinase. PLOS ONE 2014, 9:e88731. 10.1371/journal.pone.0088731.
61. Joshita S., Nakazawa K., Sugiyama Y., Kamijo A., Matsubayashi K., Miyabayashi H., Furato K., Kilano K., Kawa S. Granulocyte-colony stimulating factor-producing pancreatic adenosquamous carcinoma showing aggressive clinical course. Intern. Med. 2009, 48:687-691.
62. Kaufmann S.J., Sharif K., Sharma V., McVerry B.A. Term delivery in a women with severe congenital neutropenia, treated with growth colony stimulating factor. Hum. Reprod. 1998, 13:498-499.
63. Keller P., Smalling R. Granulocyte colony-stimulating factor: animal studies for risk assessment. Int. Rev. Exp. Pathol. 1993, 34:173-188.
64. Kim C.H., Park E.J., Hwang J.Y., Hong S.H., Kim S.H., Chae H.D., Kang B.M. The effect of granulocyte colony stimulating factor and granulocyte macrophage stimulating factor on the preimplantation development and implantation in mouse embryos. Korean J. Obstet. Gynecol. 2002, 45:126-132.
65. Kirsch F., Krüger C., Schneider A. The receptor for granulocyte-colony stimulating factor (G-CSF) is expressed in radial glia during development of the nervous system. BMC Dev. Biol. 2008, 8:32-36.
66. Kordelas L., Switala M., Noppeney R., Heinemann F., Ottinger H., Beelen D.W., Horn P.A., Rebmann V. NK alloreactivity is reduced by GCSF but enhanced by plerixafor. 38th Annual Meeting of the European Group for Blood and Marrow Transplantation 2012.
67. + granulocytes. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:21248-21255.
68. Kunicki M., Lukaszuk K., Woclawek-Potocka I., Liss J., Kulwikowska P., Szczyptanska J. Evaluation of granulocyte colony-stimulating factor effects on treatment-resistant thin endometrium in women undergoing in vitro fertilization. BioMed Res. Int. 2014, ID 913235. 10.1155/2014/913235.
69. Kyo S., Kanaya T., Takakura M., Inoue M. A case of cervical cancer with aggressive tumor growth: possible autocrine growth stimulation by G-CSF and IL-6. Gynecol. Oncol. 2000, 78:383-387.
70. Lanfrancone L., Boraschi D., Ghiara P., Falini B., Grignani F., Peri G., Mantovani A., Pelicci P.G. Human peritoneal mesothelial cells produce many cytokines (granulocyte colony-stimulating factor (CSF), granulocyte-monocyte-CSF, macrophage-CSF, interleukin-1(IL-1), and IL-6) and are activated and stimulated to grow by IL-1. Blood 1992, 80:2835-2842.
71. Larsen A., Davis T., Curtis B., Gimpel S., Sims J., Cosman D., Park L., Sorensen E., March C.J., Smith C. Expression cloning of a human granulocyte colony-stimulating factor receptor: a structural mosaic of hemopoietin receptor, immunoglobulin, and fibronectin domains. J. Exp. Med. 1990, 172:1559-1571.
72. LeBeau M., Lemons R., Carrino J., Pettenati M., Souza L., Diaz M., Rowley J. Chromosomal localization of the human G-CSF gene to 17q11 proximal to the breakpoint of the t(15;17) in acute promyelotic leukemia. Blood 1987, 70:330-337.
73. Lédée N., Lombroso R., Lombardelli L., Selva J., Dubanchet S., Chaouat G., Frankenne F., Fodart J.M., Maggi E., Romagnani S., Ville Y., Piccini M.P. Cytokines and chemokines in follicular fluids and potential of the corresponding embryo: the role of granulocyte colony-stimulating factor. Hum. Reprod. 2008, 23:2001-2009.
74. Lédée N., Munaut C., Perrier dHauterive S.P., Frydman R., Frankennes F., Wainer B., Petitbarat M., Gridelet V., Chaouat G., Piccinni M.P., Foidart J.M. Follicular fluids, immunological fingerprint and infertility. J. Reprod. Immunol. 2010, 86:94-98.
75. Lédée N., Petitbarat M., Frydman R., Rahmati M., Wainer B., Dubanchet S., Foidart J., Munaut C., Piccinni M., Chaouat G. Peri-conceptual cytokine environment and consequences for human pregnancy. J. Reprod. Immunol. 2010, 86:19-26.
76. Lédée N., Petitbarat M., Rahmati M., Chaouat G., Perrier dHauterive S., Munaut C., Foidard J.M. Cytokines in follicular fluids, implantation and miscarriage. J. Reprod. Immunol. 2011, 90:133-134.
77. Lédée N., Petitbarat M., Rahmati M., Dunanchet S., Chaouat G., Sandra O., Perrier dHauterive S., Munaut C., Foidard J.M. New pre-conception immune biomarkers for clinical practice: interleukin-18, interleukin-15, and TWEAK on the endometrial side, G-CSF on the follicular side. J. Reprod. Immunol. 2011, 88:118-123.
78. Lédée N., Frydman R., Osipova A., Taieb J., Gallot V., Lombardelli L., Logiodice F., Petitbrat F., Fanchin R., Chaouat G., Achour-Frydman N., Piccini M.P. Levels of follicular G-CSF and interleukin-15 appear as noninvasive biomarkers of subsequent successful birth in modified natural in vitro fertilization/intracytoplasmatic sperm injection cycles. Fertil. Steril. 2011, 95:94-98.
79. Lédée N., Gridelet V., Ravet S., Jouan C., Gaspard O., Wenders F., Thonon F., Hincourt N., Dubois M., Foidart J.M., Frankenne F., Munaut C., Perrier dHauterive S. Proof of concept: impact of follicular G-CSF quantification on subsequent embryo transfer policy. Hum. Reprod. 2012, 27(Suppl. 2):27.
80. Lédée N., Dubanchet S., Rahmati M., Balet R., Bensussan A., Chaouat G. Follicular and endometrial immune profile of patients with severe ovarian insufficiency. Fertil. Steril. 2013, 100(Suppl. 1):347.
81. Lédée N., Gridelet V., Ravet S., Jouan C., Gaspard O., Wenders F., Thonon F., Hincourt N., Dubois M., Foidart J.M., Munaut C., Perrier dHauterive S. Impact of follicular G-CSF quantification on subsequent embryo transfer decisions: a proof of concept study. Hum. Reprod. 2013, 28:406-413.
82. Leitner G., Loidolt H., Greinix H.T., Höcker H.P., Dettke M. Granulocyte colony-stimulating factor induced allogenic peripheral stem cell donation during early pregnancy. Br. J. Haematol. 2001, 115:233-234.
83. Li Y., Calhoun D.A., Pollioti B.M., Sola M.C., al-Mulla Z., Christensen R.D. Production of granulocyte colony-stimulating factor by the human placenta at various stages of development. Placenta 1996, 17:611-617.
84. Lin C.P., Huang M.J., Liu H.J., Chang I.Y., Tsai C.H. Successful treatment of acute promyelocytic leukemia in a pregnant Jehovah's Witness with all-trans retinoic acid, rhGCSF, and erythropoietin. Am. J. Hematol. 1996, 51:251-252.
85. Liongue C., Wright C., Rusell A.P., Ward A.C. Granulocyte colony-stimulating factor receptor: stimulating granulopoiesis and much more. Int. J. Biochem. Cell Biol. 2009, 41:2372-2375.
86. Lieschke G.J., Grail D., Hodgson G., Metcalf D., Stanley E., Cheers C., Fowler K.J., Basu S., Zhan Y.F., Dunn Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization. Blood 1994, 84:1737-1746.
87. Litwin S., Lagadari M., Barrientos G., Roux M.E., Margni R., Miranda S. Comparative immunohistochemical study of M-CSF and G-CSF in feto-maternal interface in a multiparity mouse model. Am. J. Reprod. Immunol. 2005, 54:311-320.
88. Liu H., Jia D., Fu J., Zhao S., He G., Ling E.A., Gao J., Hao A. Effects of granulocyte colony stimulating factor on the proliferation and cell-fate specification of neural stem cells. Neuroscience 2009, 164:1521-1530.
89. Lucena E., Moreno-Ortiz H. Granulocyte colony-stimulating factor (G-CSF): a mediator in endometrial receptivity for a patient with polycystic ovary (PCO) undergoing in vitro maturation (IVM). BMJ Case Rep. 2013, 18:2013.
90. McCracken S.A., Grant K.E., MacKenzie I.Z., Redman C.W.G., Mardon H.J. Gestational regulation of granulocyte-colony stimulating factor receptor expression in the human placenta. Biol. Reprod. 1999, 60:790-796.
91. Makinoda S., Hirosaki N., Waseda T., Tomizawa H., Fujii R. Granulocyte colony-stimulating factor (G-CSF) in the mechanism of human ovulation and its clinical usefulness. Curr. Med. Chem. 2008, 15:604-613.
92. Makinoda S., Tomizawa H., Fujita S., Takagi H., Oka Y., Waseda T., Sasagawa T., Fujii R., Utsunomiya T. Ninety percent of luteinized unruptured follicle during clomiphene-hCG treatment can be prevented by using granulocyte colony-stimulating factor. Hum. Reprod. 2010, 25(Suppl. 1):P458.
93. Makinoda S., Shibata T., Neyatani N., Waseda T., Takagi H., Fujii R. An effective treatment against luteinized unruptured follicle (LUF) using granulocyte colony-stimulating factor (G-CSF). Int. J. Gynecol. Obstet. 2012, 119(Suppl. 3):412-413.
94. Makrigiannakis A., Karamouti M., Drakakis P., Loutradis D., Antsaklis A. Fetomaternal immunotolerance. Am. J. Reprod. Immunol. 2008, 60:482-496.
95. Marino V.J., Rogiun L.P. The granulocyte colony stimulating factor (G-CSF) activates Jak/STAT and MAPK pathways in a trophoblastic cell line. J. Cell Biochem. 2008, 103:1512-1523.
96. Matsubara K., Ochi H., Kitagawa H., Yamanaka K., Kusanagi Y., Ito M. Concentrations of serum granulocyte-colony-stimulating factor in normal pregnancy and preeclampsia. Hypertens. Pregnancy 1999, 18:95-106.
97. Matsushita K., Arima N., Yamaguchi K., Matsumoto T., Ohtsubo H., Hidaka S., Fujiwara H., Arimura K., Kukita T., Tokito Y., Ozaki A., Tei C. Granulocyte colony-stimulating factor production by adult leukemia cells. Br. J. Haematol. 2000, 111:208-215.
98. Medlock E.S., Kaplan D.L., Cecchini M., Ulich T.R., del Castillo J., Andresen J. Granulocyte colony-stimulating factor crosses the placenta and stimulates fetal rat granulopoiesis. Blood 1993, 81:916-922.
99. Meng F., Francis H., Glaser S., Han Y., DeMorrow S., Stokes A., Staloch D., Venter J., White M., Ueno Y., Reid L.M., Alpini G. Role of stem cell factor and granulocyte colony-stimulating factor in remodeling during liver regeneration. Hepatology 2012, 55:209-221.
100. Metcalf D. Clonal extinction of myelomonocytic leukemia cells by serum from mice injected with endotoxin. Int. J. Cancer 1980, 25:225-232.
101. Metcalf D. The granulocyte-macrophage colony-stimulating factors. Science 1985, 229:16-21.
102. Miller J.S., Prosper F., McCullar V. Natural killer (NK) cells are functionally abnormal and NK cell progenitors are diminished in granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cell collections. Blood 1997, 90:3098-3105.
103. Miyama M., Umesaki N., Kawabata M. Identification of the granulocyte colony-stimulation factor (G-CSF) producing cell population in human decidua and its biological action on trophoblast cell. Osaka City Med. J. 1998, 44:85-96.
104. Moore M.A.S. The clinical use of colony stimulating factors. Annu. Rev. Immunol. 1991, 9:151-191.
105. Nagata S., Tsuchiya M., Asano S., Kaziro Y., Yamazaki T., Yamamoto O., Hirata Y., Kubota N., Oheda M., Nomura H., Ono M. Molecular cloning and expression of cDNA for human granulocyte colony-stimulating factor. Nature 1986, 319:415-419.
106. Nicola N. Hemopoietic cell growth factors and their receptors. Annu. Rev. Biochem. 1989, 58:45-55.
107. Nicola N.A., Metcalf D. Binding of 125 labeled granulocyte colony-stimulating factor to normal murine hemopoietic cells. J. Cell Physiol. 1985, 124:313-319.
108. Nicola N.A., Begley C.G., Metcalf D. Identification of the human analogue of a regulator that induces differentiation in murine leukemia cells. Nature 1985, 314:625-630.
109. Niedermeier D.M., Frei-Lahr D.A., Hall P.D. Treatment of acute myeloid leukemia during the second and third trimesters of pregnancy. Pharmacotherapy 2005, 25:1134-1140.
110. Niedzwiedzka-Rystwej P., Herberg M., Deptula W. Biology and role of NK cells: selected data. Cent. Eur. J. Immunol. 2012, 37:399-404.
111. Nioche S., Tazi A., Lecossier D., Hance A.J. Production of granulocyte colony-stimulating factor (G-CSF) by human cells: T lymphocyte-dependent and T lymphocyte-independent release of G-CSF by blood monocytes. Eur. J. Immunol. 1988, 18:1021-1026.
112. Nomura H., Imazeki I., Oheda M., Kubota N., Tamara M., Onp M., Ueyama Y., Asano S. Purification and characterization of human granulocyte colony-stimulating factor (G-CSF). EMBO J. 1986, 5:871-878.
113. North Wales Cancer Network Guidelines for the Use of Granulocyte Colony Stimulating Factors in Adult Oncology and Haematology Patients 2009.
114. Novales J.S., Salva A.M., Modanlou H.D., Kaplan D.L., Castillo J., Andresen J., Medlock E.S. Maternal administration of granulocyte colony-stimulating factor improves neonatal rat survival after a lethal group B streptococcal infection. Blood 1993, 81:923-926.
115. Okasaki K., Funato M., Kashima M., Nakama K., Inoue T., Hiura M., Kato Y., Nagata R. Twenty-six-week repeat-dose toxicity study of recombinant human granulocyte colony-stimulating factor derivative (nartograstim) in cynomolgus monkeys. Toxicol. Sci. 2002, 65:246-255.
116. + cells in cancer animal models. Int. Immunol. 2006, 18:1-9.
117. Osipova A., Piccinni M.P., Taieb J., Gallot V., Lombardelli L., Petitbarat M., Fanchin R., Chaouat G., Frydman N., Frydman R., Lédée N. The value of follicular fluid G-CSF as a biomarker of embryo implantation potential in monofollicular IVF cycle. Mol. Human. Reprod. 2009, 24(Suppl. 1):48.
118. Pala H.G., Pala E.E., Artunc Ulkumen B., Aktug H., Yavasoglu A., Korkmaz H.A., Erbas O. The protective effect of granulocyte colony-stimulating factor on endometrium and ovary in a rat model of diabetes mellitus. Gynecol. Obstet. Invest. 2014, 78:94-100.
119. Pampfer S., Arceci R.J., Pollard J.W. Role of colony stimulating factor-1 (CSF 1) and other lympho-hematopoietic growth factors in mouse preimplantation development. Bioessays 1991, 10:535-540.
120. Pessach I., Shimoni A., Nagler A. Granulocyte-colony stimulating factor for hematopoietic stem cell donation from healthy female donors during pregnancy and lactation: what do we know?. Hum. Reprod. Update 2013, 19:259-267.
121. Piccinni M.P., Sérazin V., Lombardelli L., Petitbarat M., Logiodice F., Wainer R., Hammoud I., Chaouat G., Frankenne F., Foidart J.M., Lédée N. Appropriate methodology for the measurement of follicular fluid G-CSF, which is a non-invasive and prospective marker for successful implantation. Mol. Hum. Reprod. 2009, 24(Suppl. 1):47.
122. Pulsipher M.A., Chitphakdithai P., Miller J.P., Logan B.R., King R.J., Rizzo J.D., Leitman S.P., Anderlini P., Haagenson M.D., Kurian S., Klein H.P., Horrowitz M.M., Confer D.L. Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program. Blood 2009, 113:3604-3611.
123. Rapoport A.P., Abboud C.N., DiPersio J.F. Granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF): receptor biology, signal transduction, and neutrophil activation. Blood Rev. 1992, 6:43-57.
124. Raynor B.D., Clark P., Duff P. Granulocyte colony-stimulating factor in amniotic fluid. Infect. Dis. Obstet. Gynecol. 1995, 3:140-144.
125. Reynoso E.E., Huerta F. Acute leukemia and pregnancy: fatal fetal outcome after exposure to idarubicin during the second trimester. Acta Oncol. 1994, 33:703-716.
126. Reynoso E.E., Shepard F.A., Messner H.A., Farquharson H.A., Garvey M.B., Baker M.A. Acute leukemia during pregnancy: the Toronto leukemia study group experience with long-term follow-up of children exposed to in utero chemotherapeutic agents. J. Clin. Oncol. 1987, 5:1098-1106.
127. Ridwan S., Bauer H., Frauenknecht K., Hefti K., von Pein H., Sommer C.J. Distribution of the hematopoietic growth factor G-CSF and its receptor in the adult human brain with specific reference to Alzheimer's disease. J. Anat. 2014, 4:377-391.
128. Rodriguez-Medina C., Sevillano-Zamarreno B., Gómez-Casares M.T., Lemes Castellano A., López-Jorge C.E., Quiroz Cervantes K., Campo C., Jiménez S., Luzardo H., de la Iglesia S., Molero T. Ectopic G-CSF production by malignant plasma cells in patients with diagnostic criteria of chronic neutrophilic leukemia. J. Bone Marrow Res. 2013, 1:1111.
129. Rosenberg P.S., Zeidler C., Bolyard A.A., Alter B.P., Bonilla M.A., Boxer L.A., Dror Y., Kinsey S., Link D.C., Newburger P.E., Shimamura A., Welte K., Dale D.C. Stable long-term risk of leukemia in patients with severe congenital neutropenia maintained on G-CSF therapy. Br. J. Haematol. 2010, 150:196-199.
130. Rutella S. Granulocyte colony-stimulating factor for the induction of T-cell tolerance. Transplantation 2007, 84:S26-S30.
131. Rutella S., Pierelli L., Bonanno G., Sica S., Ameglio F., Capoluongo E., Mariotti A., Scambia G., D'Onofrio G., Leone G. Role for granulocyte colony-stimulating factor in the generation of human T regulatory type1 cells. Blood 2002, 100:2562-2571.
132. Rutella S., Zavala F., Danese S., Kared H., Leone G. Granulocyte colony-stimulating factor: a novel mediator of T cell tolerance. J. Immunol. 2005, 175:7085-7091.
133. Sachs L. The molecular control of blood development. Science 1987, 238:1374-1381.
134. Saito S., Fukunaga R., Ichijo M., Nagata S. Expression of granulocyte colony-stimulating factor at the fetomaternal interface in murine and human pregnancy. Growth factors 1994, 10:135-143.
135. Salmassi A., Schmutzler A.G., Huang L., Hedderich J., Jonat W., Mettler W. Detection of granulocyte colony-stimulating factor and its receptor in human follicular luteinized granulosa cells. Fertil. Steril. 2004, (Suppl. 1):786-791.
136. Salmassi A., Schmutzler A.G., Schäfer S., Koch K., Hedderich J., Jonat W., Mettler L. Is granulocyte colony-stimulating factor level predictive for human IVF outcome?. Hum. Reprod. 2005, 20:2434-2440.
137. Sangalli M.R., Peek M., McDonald A. Prophylactic granulocyte colony-stimulating factor treatment for acquired chronic severe neutropenia in pregnancy. Aust. N. Z. J. Obstet. Gynecol. 2001, 41:470-471.
138. Santjohanser C., Franz C., Wuerfel W., Meri O., Fiedler K., Krüsmann G., Krüsmann J., Hirv K., Toth B. 564 cycles with G-CSF application in patients with fertility disorders. J. Reprod. Immunol. 2011, 90(159):S51.
139. Santjohanser C., Knieper C., Franz C., Hirv K., Meri O., Schleyer M., Würfel W., Toth B. Granulocyte-colony stimulating factor as treatment option in patients with recurrent miscarriage. Arch. Immunol. Ther. Exp. (Warsz) 2013, 61:159-164.
140. Savarese D.M., Valinski H., Queensberry P., Savarese T. Expression and function of colony-stimulating factors and their receptors in human prostate carcinoma cell lines. Prostate 1998, 1:80-91.
141. Savarese T.M., Mitchell K., McQuain C., Campbell C.L., Guardiani R., Wuu J., Ollari C., Reale F., Nelson B.E., Chen A., Quesenberry P.J. Coexpression of granulocyte colony stimulating factor and its receptor in primary ovarian carcinoma. Cancer Lett. 2001, 162:105-115.
142. Sawa Y., Horie Y., Yamaoka Y., Ebata N., Yoshida S. Production of colony-stimulating factor in human dental pulp fibroblasts. J. Dent. Res. 2003, 82:96-100.
143. Sbracia M., Scarpelini F. G-CSF treatment increases Treg peripheral blood levels in women with recurrent miscarriage. J. Reprod. Immunol. 2012, 94:12-13.
144. Scarpellini F., Sbracia M. Use of colony-stimulating factor for the treatment of unexplained recurrent miscarriage: a randomized controlled trial. Hum. Reprod. 2009, 11:2703-2708.
145. Scarpellini F., Sbracia M. G-CSF treatment improves IVF outcome in women with recurrent implantation failure in IVF. J. Reprod. Immunol. 2012, 94:103.
146. Scarpellini, F., Sbracia, M., 2014. Use of G-CSF in in vitro culture. European patent, pending, WO2014044382 A1.
147. Schlahsa L., Jaimes Y., Blasczyk R., Figueiredo C. Granulocyte-colony-stimulatory factor: a strong inhibitor of natural killer cell function. Transfusion 2011, 51:293-305.
148. Schneider A., Krüger C., Steigleder T., Weber D., Pitzer C., Laage R., Aronowski J., Maurer M.H., Gassler N., Mier W., Hasselblatt M., Kollmmar R., Schwab S., Sommer C., Bach A., Kuhn H.G., Schäbitz W.R. The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis. J. Clin. Invest. 2005, 115:2083-2098.
149. Seymour J.F., Lieschke G.J., Grail D., Quilici C., Hodgson G., Dunn A.R. Mice lacking both granulocyte colony-stimulating factor (CSF) and granulocyte-macrophage CSF have impaired reproductive capacity, perturbed neonatal granulopoiesis, lung disease, amyloidosis, and reduced long-term survival. Blood 1997, 90:3037-3049.
150. Sharma R., Das A. Organ-specific phenotypic and functional features of NK cells in humans. Immunol. Res. 2014, 58:125-131.
151. Shimoda K., Okamura S., Harada N., Kondo S., Okamura T., Niho Y. Identification of a functional receptor for granulocyte colony-stimulating factor on platelets. J. Clin. Invest. 1993, 91:1310-1313.
152. Shimoda K., Feng J., Murakami H., Nagata S., Watling D., Rogers N.C., Stark G.R., Kerr I.M., Ihle J.N. Jak1 plays an essential role for receptor phosphorylation and Stat activation in response to granulocyte colony-stimulating factor. Blood 1997, 90:572-604.
153. Shorter S.C., Vinve G.S., Starkey P.M. Production of granulocyte colony-stimulating factor at the materno-fetal interface in human pregnancy. Immunology 1992, 75:468-474.
154. Siu B.L., Alonso M.R., Vargo T.A., Fenrich A.L. Transient dilated cardiomyopathy in a newborn exposed to idarubicin and all-trans-retinoic acid (ATRA) early in the second trimester of pregnancy. Int. J. Gynecol. Cancer 2002, 12:399-402.
155. Skaznik-Wikiel M.E., Sharma R.K., Selesniemi K., Lee H.J., Tilly J.L., Falcone T. Granulocyte colony-stimulating factor in conjunction with vascular endothelial growth factor maintains primordial follicle numbers in transplanted mouse ovaries. Fertil. Steril. 2011, 95:1405-1409.
156. Skaznik-Wikiel M.E., Donohue J., Sukhwani M., Orwig K.E. Granulocyte colony-stimulating factor and leuprolide have similar efficacy in preserving ovarian function in mice treated with high-dose chemotherapy. Fertil. Steril. 2013, 100(Suppl. 1):65.
157. Skaznik-Wikiel M.E., McGuire M.M., Sukhwani M., Donohue J., Chu T., Krivak T.C., Rajkovic A., Orwig K.E. Granulocyte colony-stimulating factor with or without stem cell factor extends time to premature ovarian insufficiency in female mice treated with alkylating chemotherapy. Fertil. Steril. 2013, 99:2045-2054.
158. Sloand E.M., Kim S., Maciejewski J.P., van Rhee F., Chaudhuri A., Barrett J., Young N.S. Pharmacologic doses of granulocyte colony-stimulating factor affect cytokine production by lymphocytes in vitro and in vivo. Blood 2000, 95:2269-2274.
159. Souza L.M., Boone T.C., Gabrilove J., Lai P.H., Zsebo K.M., Murdock D.C., Chazin V.R., Bruszewski J., Lu H., Chen K.K., Barendt J., Platzer E., Moore M.A.S., Mertelsmann R., Welte K. Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells. Science 1986, 232:61-65.
160. Su Y.C., Li S.C., Hsu C.K., Yu C.C., Lin T.J., Lee C.Y., Liao H.F. G-CSF downregulates natural killer cell-mediated cytotoxicity in donors for hematopoietic SCT. Bone Marrow Transplant. 2012, 47:73-81.
161. Taga T., Kariya Y., Shimada M., Uchida A. Suppression of natural killer cell activity by granulocytes in patients with aplastic anemia: role of granulocyte colony-stimulating factor. Immunol. Lett. 1993, 39:65-70.
162. Tkatch L.S., Tweardy D.J. Human granulocyte colony-stimulating factor (G-CSF), the premier granulopoietin: biology, clinical utility, and receptor structure and function. Lymphokine Cytokine Res. 1993, 12:477-488.
163. Tomizawa H., Fujita S., Oka Y., Takagi H., Waseda T., Fujii R., Sasagewa T., Makinoda S. Novel treatment for luteinized unruptured follicle (LUF) using granulocyte colony-stimulating factor (G-CSF). J. Reprod. Endocrinol. 2010, 7:269-270.
164. Tomizawa H., Makinoda S., Fujita S., Waseda T., Fujii R., Utsunomiya T. A novel treatment of luteinized unruptured follicle caused by ovulation induction using clomiphene and human chorionic gonadotropin. Hum. Reprod. 2011, 26(Suppl. 1):313.
165. Toth B., Jeschke U., Rogenhofer N., Scholz C., Würfel W., Thaler C., Makigiannakis A. Recurrent miscarriage: current concepts in diagnosis and treatment. J. Reprod. Immunol. 2010, 85:25-32.
166. Toth B., Würfel W., Germeyer A., Hirv K., Makrigiannakis A., Strowitzki T. Disorders of implantation - are there diagnostic and therapeutic options?. J. Reprod. Immunol. 2011, 90:117-123.
167. Toth B., Würfel W., Bohlmann M.K., Gillessen-Kaesbach G., Nawroth F., Rogenhofer N., Tempfer C., Wischmann T., von Wolff M. Diagnostik und Therapie beim wiederholten Spontanabort. Deutsche Gesellschaft für Gynäkologie und Geburtshilfe (DGGG) und Arbeitsgemeinschaft Immunologie in der Gynäkologie und Geburtshilfe (AGIM) 2013, AWMF Reg. No. 015/050.
168. Touw I.P., Valkhof M., Erkeland S.J., Meijers K., Danen-van Oorschot A. Expression of G-CSF receptor during embryonic development in a csf3r-cre knock-in mouse model. Blood 110. 49th ASH Annual Meeting 2007, Abstract 2233.
169. Tsukuda M., Nagahara T., Yago T., Matsuda H., Yanoma S. Production of granulocyte colony-stimulating factor by head and neck carcinomas. Biotherapy 1993, 6:183-187.
170. Tweardy D.J., Anderson K., Cannizzaro L.A., Steinmann R.A., Croce C.M., Huebner K. Molecular cloning for the human granulocyte colony-stimulating factor receptor from HL-60 and mapping of the gene to chromosome region 1p32-34. Blood 1992, 79:1148-1154.
171. Umesaki N., Fukumasu H., Miyama M., Kawabata M., Ogita S. Plasma granulocyte colony stimulating factor concentrations in pregnant women. Gynecol. Obstet. Invest. 1995, 40:5-7.
172. Uzumaki H., Okabe T., Sasaki N., Hagiwara K., Takaku F., Tobita M., Yasukawa K., Ito S., Umezawa Y. Identification and characterization of receptors for granulocyte colony-stimulating factor on human placenta and trophoblast cells. Proc. Natl. Acad. Sci. U. S. A. 1989, 86:9323-9326.
173. Vellenga E. The expression and regulation of G-CSF and GM-CSF. Haematol. Blood Transf. 1996, 37:131-133.
174. Van de Gejin G.J., Aarts L.H., Erkeland S.J., Prasher J.M., Touw I.P. Granulocyte colony-stimulating factor and its receptor in normal hematopoietic cell development and myeloid disease. Rev. Physiol. Biochem. Pharmacol. 2003, 149:53-71.
175. Vandermolen D.T., Gu Y. Human endometrial expression of granulocyte colony-stimulating factor (G-CSF) and its receptor, stimulation of endometrial G-CSF production by interleukin-1 beta, and G-CSF inhibition of choriocarcinoma cell proliferation. Am. J. Reprod. Immunol. 1996, 36:278-284.
176. Varla-Leftherioti M., Spyropoulou-Vlachou M., Keramitsoglou T., Papadimitropolous M., Tsekoura C., Graphou O., Papadopoulou C., Gerondi M., Stavropoulos-Giokas C. Lack of the appropriate natural killer cell inhibitory receptors in women with spontaneous abortions. Hum. Immunol. 2004, 66:65-71.
177. Voloshin T., Gingis-Velitski S., Bril R., Benayoun L., Munster M., Milsom C., Man S., Kerbel R.S., Shaked Y. G-CSF supplementation with chemotherapy can promote revascularization and subsequent tumor growth: prevention by a CXCR4 antagonist. Blood 2011, 118:3426-3435.
178. Watari K., Ozawa K., Tajika K., Tojo A., Tani K., Kamachi S., Harigaya K., Takahashi T., Sekiguchi S., Nagata S. Production of human granulocyte colony stimulating factor by various kinds of stromal cells in vitro detected by enzyme immunoassay and in situ hybridization. Stem Cells 1994, 12:416-423.
179. Welte K., Platzer E., Lu L., Gabrilove J., Levi E., Mertelsmann R., Moore M. Purification and biological characterization of human pluripotent hematopoietic colony-stimulating factor. Proc. Natl. Acad. Sci. U. S. A. 1985, 82:1526-1533.
180. Würfel W. Approaches to better implantation. J. Assist. Reprod. Genet. 2000, 17:473.
181. Würfel J.W. G-CSF treatment of patients with recurrent implantation failures (RIF) and recurrent spontaneous abortions (RSA). J. Reprod. Immunol. 2014, 101/102(15):S25.
182. Würfel W., Santjohanser C., Hirv K., Bühl M., Meri O., Laubert I., von Hertwig I., Fiedler K., Krüsmann J., Krüsmann G. Hum. Reprod. 2010, 25:2151-2153.
183. Yanagi K., Makinoda S., Fujii R., Miyazaki S., Fujita S., Tomizawa H., Yoshida K., Iura T., Takegami T., Nojima T. Cyclic changes of granulocyte colony-stimulating factor (G-CSF) mRNA in the human follicle during the normal menstrual cycle and immunolocalization of G-CSF protein. Hum. Reprod. 2002, 17:3046-3052.
184. Yu L., Ping P., Xiaoli C., Lin L., Yi L., Dongzi Y. Granulocyte colony-stimulating factor administration for infertile women with thin endometrium in frozen embryo transfer program. Reprod. Sci. 2014, 3:381-385.
185. Zeidler C., Grote U.A., Nickel A., Brand B., Carlsson G., Cortesao E., Dufour C., Duhem C., Notheis G., Papadaki H.A., Tamary H., Tjonnfjord G.E., Tucci F., van Droogenbroeck J., Vermylen C., Voglova J., Xicoy B., Welte K. Outcome and management of pregnancies in severe chronic neutropenia patients by the European branch of Severe Chronic Neutropenia International Registry. Haematologica 2014, 99:1395-1402.
186. Zeyneloglu H.B., Onalan G., Durak T., Alyazici I., Unal E. Granulocyte macrophage colony stimulating factor (G-CSF) administration for art patients with repeated implantation failure (RIF): which route is best?. Fertil. Steril. 2013, 100:S291-S292.
187. Zhao J., Tian T., Zhang Q., Wang Y., Yanping L. Use of granulocyte colony-stimulating factor for the treatment of thin endometrium in experimental rats. PLOS ONE 2013, 8(12):e82375. 10.1371/journal.pone.0082375.
188. Ziebe S., Loft A., Povlsen B.B., Erb K., Agerholm I., Aasted M., Gabrielsen A., Hnida C., Zobel D.P., Munding B., Bendz S.H., Robertson S.A. A randomized clinical trial to evaluate the effect of granulocyte-macrophage colony-stimulating factor (GM-CSF) in embryo culture medium for in vitro fertilization. Fertil. Steril. 2013, 99:1600-1609.